Stereotaxis
Stereotaxis develops robotic cardiology instrument navigation systems that enhances the treatment of arrhythmias and coronary diseases. Learn more
Launch date
Employees
Market cap
$186m
Enterprise valuation
$182m (Public information from Sep 2024)
Share price
$1.95 STXS
Saint-Louis Département de Saint-Louis (HQ)
Authorizing premium user...